It’s more than just a matter of time.
I have discussed many times on Monitor Mondays the controversial Food and Drug Administration (FDA) accelerated approval of Aduhelm, the intravenous medication for Alzheimer’s dementia – and the correct decision by the Centers for Medicare & Medicaid Services (CMS) to only cover the medication in clinical trials.
Well, last week trial results were released for another drug, lecanemab, in the same class, and also seeking FDA accelerated approval. And as with Aduhelm, there was significant improvement in amyloid plaque in the brain, but the clinical improvement, while statistically significant, was not clinically significant, with a difference of 0.45 on an 18-point scale.
Now, will more time show more clinical improvement? We all hope so, but it is too early to say. Also of note was that two patients who received the medication died from brain hemorrhage. It will be interesting to see the FDA review results, and ultimately the CMS decision on this drug.
Speaking of accelerated approval, as a reminder, there is an FDA program for important drugs to be provisionally approved while awaiting definitive studies. Well, last week a drug approved under accelerated approval was withdrawn from the market. The drug, Sulfamylon, is used for treatment of burns. Now, a drug withdrawal is not unusual, but this case is. The drug was approved under accelerated approval in 1998, and now, 24 years later, the drug company determined that they cannot afford the trial required to get full approval. Yep: for 24 years, the FDA allowed an unproven medication to be used. One has to wonder about a system that allows this to happen.
Last week also saw the publication of a study looking at the effectiveness of spinal cord stimulators for chronic pain. In this trial of patients with past lumbar surgery, every patient was treated with the standard of having a trial period prior to the actual implantation, and every patient that had benefit had the device implanted. But then the stimulators were programmed to either give the proper cord stimulation or stimulation at a frequency that can best be described as a placebo. And the pain relief experienced by both groups appeared to be equal. Of course, this was not a definitive study, and limited to a small subset of patients with chronic lumbar pain, but it should lead to a careful analysis to determine for whom these devices truly add benefit.
Next, some of you may have heard that the mayor of New York City is directing police and healthcare workers to hospitalize unhoused mentally ill patients involuntarily, even if they do not pose a risk to themselves or others.
Now, of course, this has huge legal, ethical, and financial implications, but I won’t address those – but rather point out that I doubt any hospital in New York City, or the country has the capacity and resources to care for these patients. In fact, the access to inpatient psychiatric care for patients is currently at an unsustainably low level.
Now, is this a welcome first step by a government to address the issue of the unhoused that was simply not well thought-out? Time will tell. I do not think anyone would disagree that more resources are necessary to address the social determinants of health (SDoH).
Programming note: Listen to Dr. Ronald Hirsch as he makes his rounds every Monday on Monitor Mondays and sponsored by R1 Physician Advisor Solutions.
There has been a noticeable increase in payer actions regarding readmission denials, often justified as efforts to enhance quality of care and align with Medicare’s
The Centers for Medicare & Medicaid Services (CMS) released in its 2025 Outpatient Prospective Payment System (OPPS) Final Rule a new Conditions of Participation (CoPs)
Please log in to your account to comment on this article.
Join Beth Wolf, MD, CPC, CCDS, for an in-depth webcast on the FY2025 spinal fusion MS-DRG updates. Discover key changes in DRG classification, understand impacts on documentation and CMI, and learn strategies to ensure compliance.
Join Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, as she presents effective strategies to strengthen collaboration between CDI, coding, and quality departments in acute care hospitals. Angela will also share guidance on implementing cross-departmental meetings, using shared KPIs, and engaging leadership to foster a culture of collaboration. Attendees will gain actionable tools to optimize documentation accuracy, elevate quality metrics, and drive a unified approach to healthcare goals, ultimately enhancing both patient outcomes and organizational performance.
Optimize your outpatient clinical documentation and gain comprehensive knowledge from foundational practices to advanced technologies, ensuring improved patient care and organizational and financial success. This webcast bundle provides a holistic approach to outpatient CDI, empowering you to implement best practices from the ground up and leverage advanced strategies for superior results. You will gain actionable insights to improve documentation quality, patient care, compliance, and financial outcomes.
Enhancing outpatient clinical documentation is crucial for maintaining accuracy, compliance, and proper reimbursement in today’s complex healthcare environment. This webcast, presented by industry expert Angela Comfort, DBA, RHIA, CDIP, CCS, CCS-P, will provide you with actionable strategies to tackle complex challenges in outpatient documentation. You’ll learn how to craft detailed clinical narratives, utilize advanced EHR features, and implement accurate risk adjustment and HCC coding. The session also covers essential regulatory updates to keep your documentation practices compliant. Join us to gain the tools you need to improve documentation quality, support better patient care, and ensure financial integrity.
Dr. Ronald Hirsch provides critical details on the new Medicare Appeal Process for Status Changes for patients whose status changes during their hospital stay. He also delves into other scenarios of hospital patients receiving custodial care or medically unnecessary services where patient notifications may be needed along with the processes necessary to ensure compliance with state and federal guidance.
Healthcare organizations face complex regulatory requirements under the No Surprises Act and Price Transparency rules. These policies mandate extensive fee disclosures across settings, and confusion is widespread—many hospitals remain unaware they must post every contracted rate. Non-compliance could lead to costly penalties, financial loss, and legal risks. Join David M. Glaser Esq. as he shows you how to navigate these regulations effectively.
Protect your facility from unwanted audits! Join Becky Jacobsen, BSN, RN, MBS, CCS-P, CPC, CPEDC, CBCS, CEMC, and take a deep dive into both the CMS and AMA guidelines for reporting post operative pain blocks. You’ll learn how to determine if the nerve block is separately codable with real life examples for better understanding. Becky will also cover how to evaluate whether documentation supports medical necessity, offer recommendations for stronger documentation practices, and provide guidance on educating providers about documentation requirements. She’ll include a discussion of appropriate modifier and diagnosis coding assignment so that you can be confident that your billing of post operative pain blocks is fully supported and compliant.
During this RACmonitor webcast Dr. Ronald Hirsch spotlights the areas of the OIG’s Work Plan and the findings of their most recent audits that impact utilization review, case management, and audit staff. He also provides his common-sense interpretation of the prevailing regulations related to those target issues. You’ll walk away better equipped with strategies to put in place immediately to reduce your risk of paybacks, increased scrutiny, and criminal penalties.
Copyright © 2024 ICD10monitor. Powered by MedLearn Media.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
